Chugai Pharmaceutical Co Ltd Digital Strategy Meeting Transcript
Good afternoon, everyone. I'm Satoko Shisai, Vice President, Head of Digital and IT Supervisory Division at Chugai Pharmaceutical. Thank you very much for joining this meeting in person or via Zoom today. I would like to give you an overview of Chugai Digital Vision 2030.
First of all, as you can see here, why does digital technology, digital transformation or Dx matter in the pharmaceutical industry right now? There is a recent trend for pharmaceutical companies like us focusing on drug discovery as a core business. You can see R&D productivity of mega pharma on the left side of this page. Productivity has been falling vis-a-vis costs required to generate one innovative new drug. It requires a lot of cost and time for very difficult drug discovery, resulting in lower productivity.
The right side of this page shows the analysis by Dr. Okuno of Kyoto University. There have been 3 major challenges in conventional drug discovery. First, the duration required, from basic research to approval, has been more than 10 years. And costs have been rising, as I mentioned before. The
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |